2005

Cockburn, Iain, Furman, Jeff, Henderson, Rebecca and Kyle, Margaret (2005) Public and Private Spillovers, Location, and the Productivity of Pharmaceutical Research. Annales d'Économie et de Statistique (79-80). pp. 165-188.

2006

Kyle, Margaret (2006) The Role of Firm Characteristics in Pharmaceutical Product Launches. RAND Journal of Economics, 37 (3). pp. 602-618.

2007

Kyle, Margaret and Ridley, David B. (2007) Would Greater Transparency and Uniformity Of Health Care Prices Benefit Poor Patients? Health Affairs, 26 (5). pp. 1384-1391.

Grabowski, Henry and Kyle, Margaret (2007) Generic Competition and Market Exclusivity Periods in Pharmaceuticals. Managerial and Decision Economics, 28 (4-5). pp. 491-502.

Kyle, Margaret (2007) Pharmaceutical Price Controls and Entry Strategies. Review of Economics and Statistics, 89 (1). pp. 88-99.

2008

Allsbrook, Jennifer, Kyle, Margaret and Schulman, Kevin (2008) Does Re-importation Reduce Price Differences for Prescription Drugs? Lessons from the European Union. Health Services Research, 43 (4). pp. 1308-1324.

2009

Grace, Cheri and Kyle, Margaret (2009) Comparative Advantages of Push and Pull Incentives for Technology Development: Lessons for Neglected Diseases. In: Global Forum Update on Research for Health Global Forum Update on Research for Health. pp. 147-152. ISBN 978-2-940401-24-6

2010

Kyle, Margaret (2010) Parallel Trade in Pharmaceuticals: Firm Responses and Competition Policy. In: International Antitrust Law & Policy: Fordham Competition Law 2009 Hawk, Barry E. (ed.) Juris Publishing. Chapter 13. ISBN 978-1-57823-265-9

Bärnighausen, Till, Diedrichsen, Ellen, Hochstadt, Jenny, Kyle, Margaret, Moon, Suerie, Soucy, Lyne and Waning, Brenda (2010) Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Globalization and Health, 6 (9).

2011

Bärnighausen, Till, Kyle, Margaret, Salomon, Joshua and Waning, Brenda (2011) Assessing the population health impact of market interventions to improve access to antiretroviral treatment. Health Policy and Planning, 27 (6). pp. 467-476.

Kyle, Margaret (2011) Strategic Responses to Parallel Trade. B. E. Journal of Economic Analysis & Policy (Advances), 11 (2). pp. 1-32.

2012

Kyle, Margaret and McGahan, Anita M. (2012) Pharmaceutical Investments Before and After TRIPS. Review of Economics and Statistics, 94 (4). pp. 1157-1172.

Grabowski, Henry and Kyle, Margaret (2012) Consolidation and Productivity in the Pharmaceutical Industry. In: Handbook of the Economics of the BioPharmaceutical Industry Handbook of the Economics of the BioPharmaceutical Industry. Chapter 18.

2013

Delgado, Mercedes, Kyle, Margaret and McGahan, Anita M. (2013) Intellectual Property Protection and the Geography of Trade. Journal of Industrial Economics, 61 (3). pp. 733-762.

Allain, Marie-Laure, Henry, Emeric and Kyle, Margaret (2013) Competition and the Efficiency of Markets for Technology. TSE Working Paper, n. 13-416

2016

Dubois, Pierre and Kyle, Margaret (2016) The Effects of Pharmaceutical Innovation on Cancer Mortality Rates. TSE Working Paper, n. 16-688